Skip to main content
  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

AACR logo

  • Register
  • Log in
  • My Cart
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Focus on Computer Resources
      • Highly Cited Collection
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Early Career Award
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citations
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in
  • My Cart

Search

  • Advanced search
Cancer Research
Cancer Research
  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Focus on Computer Resources
      • Highly Cited Collection
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Early Career Award
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citations
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

Experimental Therapeutics

Growth Inhibition, Tumor Maturation, and Extended Survival in Experimental Brain Tumors in Rats Treated with Phenylacetate

Zvi Ram, Dvorit Samid, Stuart Walbridge, Eric M. Oshiro, John J. Viola, Jung-Hwa Tao-Cheng, Sonsoles Shack, Alain Thibault, Charles E. Myers and Edward H. Oldfield
Zvi Ram
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Dvorit Samid
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Stuart Walbridge
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Eric M. Oshiro
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
John J. Viola
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jung-Hwa Tao-Cheng
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sonsoles Shack
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alain Thibault
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Charles E. Myers
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Edward H. Oldfield
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI:  Published June 1994
  • Article
  • Info & Metrics
  • PDF
Loading

Abstract

Phenylacetate is a naturally occurring plasma component that suppresses the growth of tumor cells and induces differentiation in vitro. To evaluate the in vivo potential and preventive and therapeutic antitumor efficacy of sodium phenylacetate against malignant brain tumors, Fischer 344 rats (n = 50) bearing cerebral 9L gliosarcomas received phenylacetate by continuous s.c. release starting on the day of tumor inoculation (n = 10) using s.c. osmotic minipumps (550 mg/kg/day for 28 days). Rats with established brain tumors (n = 12) received continuous s.c. phenylacetate supplemented with additional daily i.p. dose (300 mg/kg). Control rats (n = 25) were treated in a similar way with saline. Rats were sacrificed during treatment for electron microscopic studies of their tumors, in vivo proliferation assays, and measurement of phenylacetate levels in the serum and cerebrospinal fluid.

Treatment with phenylacetate extended survival when started on the day of tumor inoculation (P < 0.01) or 7 days after inoculation (P < 0.03) without any associated adverse effects. In the latter group, phenylacetate levels in pooled serum and cerebrospinal fluid samples after 7 days of treatment were in the therapeutic range as determined in vitro (2.45 mm in serum and 3.1 mm in cerebrospinal fluid). Electron microscopy of treated tumors demonstrated marked hypertrophy and organization of the rough endoplasmic reticulum, indicating cell differentiation, in contrast to the scant and randomly distributed endoplasmic reticulum in tumors from untreated animals. In addition, in vitro studies demonstrated dose-dependent inhibition of the rate of tumor proliferation and restoration of anchorage dependency, a marker of phenotypic reversion.

Phenylacetate, used at clinically achievable concentrations, prolongs survival of rats with malignant brain tumors through induction of tumor differentiation. Its role in the treatment of brain tumors and other cancers should be explored further.

Footnotes

  • ↵1 The work was supported in part by funds from Elan Pharmaceutical Research Corporation through a cooperative research and development agreement (CACR-0139).

  • ↵2 To whom requests for reprints should be addressed, at Surgical Neurology Branch, NINDS, NIH, Bldg. 10, Room 5D-37, 9000 Rockville Pike, Bethesda, MD 20892.

  • Received September 29, 1993.
  • Accepted March 29, 1994.
  • ©1994 American Association for Cancer Research.
PreviousNext
Back to top
June 1994
Volume 54, Issue 11
  • Table of Contents
  • Table of Contents (PDF)
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)

Sign up for alerts

Open full page PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Cancer Research article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Growth Inhibition, Tumor Maturation, and Extended Survival in Experimental Brain Tumors in Rats Treated with Phenylacetate
(Your Name) has forwarded a page to you from Cancer Research
(Your Name) thought you would be interested in this article in Cancer Research.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Growth Inhibition, Tumor Maturation, and Extended Survival in Experimental Brain Tumors in Rats Treated with Phenylacetate
Zvi Ram, Dvorit Samid, Stuart Walbridge, Eric M. Oshiro, John J. Viola, Jung-Hwa Tao-Cheng, Sonsoles Shack, Alain Thibault, Charles E. Myers and Edward H. Oldfield
Cancer Res June 1 1994 (54) (11) 2923-2927;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Growth Inhibition, Tumor Maturation, and Extended Survival in Experimental Brain Tumors in Rats Treated with Phenylacetate
Zvi Ram, Dvorit Samid, Stuart Walbridge, Eric M. Oshiro, John J. Viola, Jung-Hwa Tao-Cheng, Sonsoles Shack, Alain Thibault, Charles E. Myers and Edward H. Oldfield
Cancer Res June 1 1994 (54) (11) 2923-2927;
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
  • PDF
Advertisement

Related Articles

Cited By...

More in this TOC Section

Experimental Therapeutics

  • Phosphatidylinositol 3′-Kinase Is Required for Growth of Mast Cells Expressing the Kit Catalytic Domain Mutant
  • Antitumor Effect by Interleukin-11 Receptor α-Locus Chemokine/CCL27, Introduced into Tumor Cells through a Recombinant Adenovirus Vector
  • Mammary Carcinoma Suppression by Cellular Retinoic Acid Binding Protein-II
Show more Experimental Therapeutics

Articles

  • The Phenotypes Associated with ret Mutations in the Multiple Endocrine Neoplasia Type 2 Syndrome
  • Conference Participants
  • Insights from Bcl-2 and Myc: Malignancy Involves Abrogation of Apoptosis as well as Sustained Proliferation
Show more Articles
  • Home
  • Alerts
  • Feedback
  • Privacy Policy
Facebook  Twitter  LinkedIn  YouTube  RSS

Articles

  • Online First
  • Current Issue
  • Past Issues
  • Meeting Abstracts

Info for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians

About Cancer Research

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2021 by the American Association for Cancer Research.

Cancer Research Online ISSN: 1538-7445
Cancer Research Print ISSN: 0008-5472
Journal of Cancer Research ISSN: 0099-7013
American Journal of Cancer ISSN: 0099-7374

Advertisement